author-photo

Rebecca Kristeleit

Guy's and St Thomas' NHS Foundation Trust

7

Papers

25

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Safety, anti-tumor activity and T-cell responses in a dose-ranging phase 1 trial of the oncolytic peptide LTX-315 in patients with solid tumors

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.

2021 International Journal of Gynecological Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Subgroup analysis of rucaparib versus chemotherapy as treatment for BRCA-mutated, advanced, relapsed ovarian carcinoma: Effect of platinum sensitivity in the randomized, phase 3 study ARIEL4.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1Rucaparib versus chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: efficacy and safety from ARIEL4, a randomized phase III study

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (0)